Feel free to download the slide deck of one of our recent talks on the proactive pharmacovigilance which was presented by Sonia Mangnoesing at the PhV Day on October 10th, 2018.
With the changes in Pharmacovigilance regulations over the last years, a shift has been seen in how we conduct Pharmacovigilance. Moving from a more reactive approach to a proactive approach. Maybe also moving from the ‘person’s approach’ to the ‘human factors’ approach. But why is this important, what are the benefits? That is a question many of us can answer in a fairly good way. Some may have had the opportunity to experience its benefits more than others, but since the changes in regulation, most will agree that this is the way forward.
Yet, when we look at how Pharmacovigilance is executed in practice, we too often see that different challenges cause a less than optimal Pharmacovigilance system. The challenges that we all can face in pharmacovigilance are not unique, but rather universal and their solutions hopefully applicable to different settings.